Private Equity
The California concentrated dental company is in the second rounds of its sponsor-focused sales process.
3 min read · 26 November 2019
CrossRoads Extremity Systems, which is backed by HealthpointCapital, has acquired several tech assets from Logan, Utah-based Surgical Frontiers LLC, a developer of advanced surgical technologies.
4 min read · 25 November 2019
Teasers have been distributed to a narrow group of potential bidders and an initial bid date is not certain
2 min read · 25 November 2019
European investor Kartesia has purchased ClearLight-backed Richardson, a provider of tech-enabled, enterprise sales training solutions to the 'Global 1000', BusinessWeek's list of the world's thousand top companies by market capitalization.
2 min read · 25 November 2019
Blackstone Life Sciences and Ferring Pharmaceuticals will invest $570 million in FerGene, a new gene therapy company. According to terms of the joint venture, Blackstone will invest $400 million while Ferring will invest up to $170 million.
5 min read · 25 November 2019
Accuity Delivery Systems, the WindRose Health Investors-backed provider of outsourced revenue cycle management services to hospitals, is exploring a sale, according to four sources.
2 min read · 22 November 2019
Tokyo-based Heartseed Inc, a biotechnology company developing iPSC-derived cardiomyocytes for the treatment of heart failure, has raised about $26 million in Series B funding. The investors were SBI Investment, JMDC, Gene Techno Science, Nissay Capital, SMBC Capital and Astellas Venture Management LLC.
1 min read · 22 November 2019
New Jersey-based Analytical Wizards, a healthcare analytics firm, has secured Series A funding from Sopris Capital. No financial terms were disclosed.
1 min read · 21 November 2019
Rightway Healthcare, a New York-based enterprise healthcare platform, has raised $20 million in Series B funding. Thrive Capital led the round.
1 min read · 21 November 2019
Toronto-based EBT Medical, a pelvic health startup, has secured US$10 million in Series A funding. SV Health Investors and Genesys Capital led the round. The capital will be used for expansion, product development and general administrative purposes.
1 min read · 21 November 2019